openPR Logo

Press Releases by Category Health & Medicine

RSS-Newsfeed

Epilepsy Therapeutics Market Outlook 2031: From US$ 10.6 Billion in 2021 to US$ …

The global epilepsy therapeutics market, valued at US$ 10.6 billion in 2021, is projected to reach US$ 14.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 3.5% from 2022 to 2031. Epilepsy therapeutics include anti-epileptic drugs (AEDs), surgical interventions, neuromodulation devices, and emerging therapies like gene therapy, addressing seizures and improving quality of life for patients with epilepsy. This article explores the market dynamics, key drivers,

Animal Healthcare Market Outlook 2028: From US$ 34.5 Billion in 2020 to US$ 63.2 …

The global animal healthcare market, valued at US$ 34.5 billion in 2020, is projected to reach US$ 63.2 billion by 2028, expanding at a compound annual growth rate (CAGR) of 7.2% from 2021 to 2028. This market encompasses veterinary pharmaceuticals, vaccines, feed additives, diagnostics, and medical devices for companion animals (e.g., dogs, cats) and livestock (e.g., cattle, poultry). This article explores the market dynamics, key drivers, challenges, and opportunities shaping

Geriatric Medicine Market Outlook 2027: From US$ 672.0 Billion in 2018 to US$ 1, …

The global geriatric medicine market, valued at US$ 672.0 billion in 2018, was projected to expand at a compound annual growth rate (CAGR) of 6.9% from 2019 to 2027, reaching approximately US$ 1,206.7 billion by the end of 2027. Geriatric medicine focuses on healthcare for the elderly, addressing chronic diseases, polypharmacy, and age-related conditions like Alzheimer's, arthritis, and cardiovascular diseases. This article provides an analysis of the market dynamics, key

Drug Eluting Balloon Market Outlook 2031: From US$ 571.1 Million in 2022 to US$ …

The global drug eluting balloon (DEB) market, valued at US$ 571.1 million in 2022, is projected to reach US$ 1.0 billion by 2031, driven by a compound annual growth rate (CAGR) of 7.1% from 2023 to 2031. Drug eluting balloons, coated with anti-proliferative drugs like paclitaxel, are used in interventional cardiology and peripheral vascular procedures to treat arterial stenosis without leaving permanent implants. This article explores the market dynamics, key

Tuberous Sclerosis Complex Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Ap …

(Albany, USA) DelveInsight's "Tuberous Sclerosis Complex Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Tuberous Sclerosis Complex, historical and forecasted epidemiology as well as the Tuberous Sclerosis Complex market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. The Tuberous Sclerosis Complex market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the

Wilson's Disease Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, M …

(Albany, USA) DelveInsight's "Wilson's Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Wilson's Disease, historical and forecasted epidemiology as well as the Wilson's Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. The Wilson's Disease market report also offers comprehensive insights into the Wilson's Disease market size, share, Wilson's Disease epidemiology, emerging therapies, market drivers and barriers,

Fabry Disease Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medi …

(Albany, USA) DelveInsight's "Fabry Disease Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Fabry Disease, historical and forecasted epidemiology as well as the Fabry Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Fabry Disease market report provides current treatment practices, emerging drugs, the market share of tmarkets. The Report also covers current Fabry Disease treatment practice/algorithm, market

Global Meningococcal Vaccines Market Analysis To Reach US$ 6.05Bn By 203 and Jap …

Meningococcal Vaccine Market Size reached US$ 3.47 Billion in 2024 and is expected to reach US$ 6.05 Billion by 2033, growing at a CAGR of 6.4% during the forecast period 2025-2033. Recent News Study in Japan: MenACWY conjugate vaccines have been available since May 2015 in Japan, but they remain classified as voluntary and are not part of the routine national immunization schedule Unlock exclusive insights with our detailed sample report (Corporate Email

Japanese Encephalitis Vaccine Market Overview & Key Growth Drivers - Japan News

Japanese Encephalitis (JE) Vaccines Market reached with a CAGR during the forecast period 2024-2031. Japan JE Vaccine & Case News - June 2025 Narita JE Cases Highlight Underestimated Risk A newly published case series in the Journal of Infection and Chemotherapy (June 2025) reported three Japanese Encephalitis cases over the past three years at a hospital in Narita, located a few miles east of Tokyo. These cases emerged in areas previously considered low-risk,
06-19-2025 | Health & Medicine
Getnews

GolfCarting Expo Announces Inaugural Dealer Summit and Industry Trade Show in Ch …

Image: https://www.globalnewslines.com/uploads/2025/06/1749694267.jpg Image by GCEvents LLC New event brings together the golf cart industry for education, networking, and technology showcase this October Charleston, SC - GC Events has announced the launch of the GolfCarting Expo & Dealer Summit [http://golfcartingexpo.com], an industry-focused gathering designed to serve professionals and businesses across the golf cart industry. The event will be held from Wednesday, October 8 to Saturday, October 11, 2025, at the Charleston Area Convention Center

Mucopolysaccharidosis I Market Set for Steady Growth Through 2034, Driven by Adv …

Mucopolysaccharidosis I (MPS I) is a rare, inherited lysosomal storage disorder caused by a deficiency in the enzyme alpha-L-iduronidase, leading to the accumulation of glycosaminoglycans (GAGs) in various tissues. This progressive disease manifests across a spectrum of severity-from the severe Hurler syndrome to attenuated forms like Hurler-Scheie and Scheie syndromes-and affects multiple organs, including the heart, bones, eyes, and central nervous system. DelveInsight's latest report, "Mucopolysaccharidosis I - Market Insight, Epidemiology,

Sarcopenia Market to See Significant Growth Through 2034, Driven by Aging Popula …

Sarcopenia is a progressive skeletal muscle disorder characterized by the loss of muscle mass, strength, and function. Recognized as a major contributor to frailty, falls, and physical disability in older adults, sarcopenia is increasingly drawing clinical and regulatory attention. Despite its growing clinical relevance, the condition remains underdiagnosed and often overlooked, leading to delays in intervention and management. Currently, there are no approved pharmacological therapies specifically for sarcopenia. Standard management revolves

Pheochromocytomas and Paragangliomas Market Forecast - Unlocking Rare Tumor Insi …

Pheochromocytomas and Paragangliomas (PCPG) are rare neuroendocrine tumors originating from chromaffin cells of the adrenal medulla and extra-adrenal paraganglia, respectively. While pheochromocytomas typically arise in the adrenal glands, paragangliomas can develop anywhere along the sympathetic and parasympathetic chains. Though generally benign, these tumors can secrete excess catecholamines, leading to severe cardiovascular complications such as hypertension, arrhythmias, and even stroke, if not diagnosed and managed promptly. DelveInsight's comprehensive report, "Pheochromocytomas and Paragangliomas

Triple Negative Breast Cancer Market Set for Steady Growth Through 2034, Driven …

Triple Negative Breast Cancer (TNBC) is one of the most aggressive and difficult-to-treat subtypes of breast cancer, accounting for approximately 10-20% of all breast cancer cases. Defined by the absence of estrogen receptor (ER), progesterone receptor (PR), and HER2 expression, TNBC lacks the benefit of targeted hormonal or HER2-directed therapies, making chemotherapy the traditional mainstay of treatment. TNBC disproportionately affects younger women and is associated with higher recurrence rates and

HER2+ Gastric Cancer Market Set for Transformative Growth Through 2034, Driven b …

HER2+ Gastric Cancer is an aggressive subtype of gastric and gastroesophageal junction cancers, defined by the overexpression of the HER2 (human epidermal growth factor receptor 2) protein. Affecting around 15-20% of gastric cancer patients, this form is associated with rapid progression and poor outcomes if left untreated. However, advancements in HER2+ Gastric Cancer treatment, particularly targeted therapies, have significantly improved survival in recent years. DelveInsight's latest report, "HER2+ Gastric Cancer -

AntiObesity Drugs Market to Reach USD 100.97 Billion by 2030, Driven by GLP1 Inc …

Mordor Intelligence has published a new report on the AntiObesity Drugs Market, offering a comprehensive analysis of trends, growth drivers, and future projections. Introduction Mordor Intelligence, in its latest antiobesity drugs market report, forecasts the market to reach from USD25.93billion in 2025 to USD100.97billion by 2030, advancing at a 31.24% CAGR. The anti-obesity drugs market [https://www.mordorintelligence.com/industry-reports/anti-obesity-drugs-market?utm_source=abnewswire] focuses on medications developed to aid in weight loss and manage obesity related conditions. Obesity is

Orthopedic Devices Market worth US$68.51 billion by 2030 with 4.8% CAGR | Market …

Emerging economies such as India and China offer several opportunities for the growth of the orthopedic devices market. The global Orthopedic Devices Market [https://www.marketsandmarkets.com/Market-Reports/orthopedic-device-280.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=orthopedicdevicesmarket], valued at US$49.63 billion in 2023, is forecasted to grow at a robust CAGR of 14.5%, reaching US$51.61 billion in 2024 and an impressive US$68.51 billion by 2030. The primary driver of the market is the increasing prevalence of orthopedic disorders, especially in the geriatric population. The

Blood Cell Factors Market Expected to Touch USD 4.31 Bn by 2032, CAGR of 3.6% De …

The global blood cell factors market growth is driven by the increasing prevalence of blood disorders, advancements in healthcare infrastructure, and rising demand for effective treatments. Additionally, growing awareness about blood cell factors and their role in treating various blood-related conditions are expected to fuel the market growth. Blood Cell Factors Market Insights The Blood Cell Factors [https://www.coherentmarketinsights.com/industry-reports/blood-cell-factors-market] industry is experiencing robust expansion driven by rising hemophilia treatment demand and novel biologics

Preventive Medicine Market Projected to Reach USD 630.7 Mn by 2032, Growing at 5 …

The preventive medicine market is witnessing a significant trend towards personalized and predictive healthcare, facilitated by advancements in genomics, big data analytics, and digital health technologies. Healthcare providers and payers are increasingly focusing on preventive care to reduce healthcare costs and improve patient outcomes. Preventive Medicine Market Insights The Preventive Medicine [https://www.coherentmarketinsights.com/industry-reports/preventive-medicine-market] industry is witnessing accelerated digital integration and public-private collaborations, driven by mounting chronic disease burdens and proactive health policies. Advanced

Medicinal Herbs Market Booming Worldwide, Forecasted to Reach USD 478.93 Bn by 2 …

The medicinal herbs market is experiencing a significant trend towards the adoption of herbal remedies and supplements for various health conditions such as digestive disorders, respiratory issues, and immune system support. Additionally, the integration of medicinal herbs into functional foods and beverages is gaining traction, as consumers seek convenient ways to incorporate these beneficial ingredients into their daily diets. Medicinal Herbs Market Insights The Medicinal Herbs Market [https://www.coherentmarketinsights.com/industry-reports/medicinal-herbs-market] is witnessing accelerated expansion

Blood Plasma Market to Witness Strong Growth at 10.8% CAGR, Expected to Hit USD …

The trend in the blood plasma industry is characterized by a growing focus on research and development activities to develop novel plasma-derived therapies, increasing collaboration between plasma collection centers and pharmaceutical companies, and the expansion of plasma collection networks worldwide. Additionally, there is a growing emphasis on improving the safety and quality of plasma-derived products through stringent regulatory guidelines and advanced testing methodologies. Blood Plasma Market Insights The blood plasma [https://www.coherentmarketinsights.com/industry-reports/blood-plasma-market] industry

Cardiac Event Monitor Market Set to Reach USD 7.39 Bn by 2032 with 5.9% CAGR | C …

The market trend for the cardiac event monitor market is driven by several factors, including the increasing prevalence of cardiovascular diseases, the growing geriatric population, and the rising adoption of remote monitoring technologies. Additionally, the development of advanced and user-friendly cardiac event monitors, coupled with the increasing demand for home-based healthcare solutions, is expected to further fuel market growth during the forecast period. Cardiac Event Monitor Market Insights The Cardiac Event Monitor

Flexible Endoscopes Market Projected to Reach USD 22.21 Billion by 2034, Growing …

The flexible endoscopes market is projected to exhibit a robust compound annual growth rate (CAGR) of 6.1% during 2025-2034. The market was valued at USD 12.31 billion in 2024 and is projected to grow to USD 22.21 billion by 2034. Market Introduction: Flexible endoscopes are advanced medical instruments intended for minimally invasive diagnostic and therapeutic procedures within the human body. Unlike rigid endoscopes, these devices feature a long, bendable insertion tube.

Ibogaine by David Dardashti Takes Center Stage on Day One of Psychedelic Science …

DENVER, CO - June 19, 2025 - Ibogaine by David Dardashti, a leading initiative in ibogaine research and advocacy, today commenced its participation in the highly anticipated Psychedelic Science Conference 2025 in Denver, Colorado. As the conference officially began its main programming today, June 18th, the presence of Ibogaine by David Dardashti marks a pivotal moment for the burgeoning field of psychedelic medicine, championing a collaborative approach to advance ibogaine's

Eisenmenger Complex Drugs Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals …

(Albany, USA) DelveInsight's "Eisenmenger Complex Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Eisenmenger Complex, historical and forecasted epidemiology as well as the Eisenmenger Complex market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. The Eisenmenger Complex market report provides current treatment practices, emerging drugs, the Eisenmenger Complex market share of individual therapies, and current and forecasted Eisenmenger

Persistent Epithelial Defect Treatment Market 2034: Clinical Trials, EMA, PDMA, …

(Albany, USA) DelveInsight's "Persistent Epithelial Defect Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Persistent Epithelial Defect, historical and forecasted epidemiology as well as the Persistent Epithelial Defect market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. The latest healthcare forecast report provides an in-depth analysis of Persistent Epithelial Defect, offering comprehensive insights into the Persistent Epithelial Defect revenue

Post-operative Cataract Surgery Inflammation Treatment Market 2034: Clinical Tri …

(Albany, USA) DelveInsight's "Post-operative Cataract Surgery Inflammation Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Post-operative Cataract Surgery Inflammation, historical and forecasted epidemiology as well as the Post-operative Cataract Surgery Inflammation market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Post-operative Cataract Surgery Inflammation market outlook, drug uptake, treatment scenario and epidemiology trends,
06-19-2025 | Health & Medicine
Fact.MR

Heart Attack Diagnostics Market is Growing at a CAGR of 7.7% by 2035 | Fact.MR

The global Heart Attack Diagnostics Market is set to experience significant growth, projected to expand from an estimated $13.3 billion in 2025 to an impressive $30.7 billion by 2035, according to a comprehensive report by Fact.MR. This robust growth, driven by a compound annual growth rate (CAGR) of 7.7%, underscores the critical role of advanced diagnostic technologies in addressing the rising global burden of cardiovascular diseases, particularly heart attacks. For More
06-19-2025 | Health & Medicine
Fact.MR

Bioabsorbable Stents Market to Surge to $1,426.3 Million by 2035 | Fact.MR

The global Bioabsorbable Stents Market is poised for remarkable growth, projected to expand from an estimated $540 million in 2025 to a staggering $1,426.3 million by 2035, according to a detailed report by Fact.MR. This robust growth, driven by a compound annual growth rate (CAGR) of 10.2%, highlights the increasing adoption of bioabsorbable stents as a revolutionary solution for treating cardiovascular diseases, fueled by technological advancements and a rising preference

Precision Medicine Market Expected to Reach USD 300.50 Billion by 2033 | Top Key …

The Precision Medicine Market reached US$ 98.87 billion in 2024 and is expected to reach US$ 300.50 billion by 2033, growing at a CAGR of 13.2% during the forecast period of 2025-2033. Key Drivers of the Precision Medicine Market in the USA: Rising prevalence of chronic diseases boosts demand for personalized treatment approaches. Advancements in genomics and biotechnology enable tailored therapies based on individual genetic profiles. Government support and funding accelerate research and implementation
06-19-2025 | Health & Medicine
Fact.MR

Anesthesia Monitoring Devices Market Set to Reach $5.2 Billion by 2032 | Fact.MR …

The global Anesthesia Monitoring Devices Market is poised for significant growth, projected to climb from a valuation of $2.2 billion in 2022 to an impressive $5.2 billion by 2032, according to a comprehensive report by Fact.MR. This robust expansion, driven by a compound annual growth rate (CAGR) of 9.1% over the forecast period from 2022 to 2032, underscores the critical role of anesthesia monitoring devices in enhancing patient safety and

Oncology Therapy Market Set to Soar: Breakthrough Treatments and Rising Cancer C …

The Global Oncology Therapy Market size reached US$ 193.98 billion in 2024 and is expected to reach US$ 440.26 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period of 2025-2033. Key Drivers of the Oncology Therapy Market in the USA: Rising cancer prevalence - Increasing cases of various cancers are driving demand for effective therapies. Advancements in precision medicine - Personalized treatment options are enhancing

Cell Line Development Market to Cross USD 14 Billion by 2031 on Biologics Boom a …

[Boston, 19th, June 2025] - According to Clearview Market Insights (CVMI), the global Cell Line Development (CLD) market is projected to reach USD 14.28 billion by 2031, up from USD 7.89 billion in 2024, growing at a CAGR of 8.9%. The demand for rapid and reproducible cell line platforms is driven by biologic therapeutics, gene therapy tools, and biosimilar launches. "High-efficiency CHO cell lines are becoming the industry standard for

Anatomic Pathology Market Booms Amid Rising Cancer Diagnoses and Precision Medic …

The Global Anatomic Pathology Market reached US$ 16.7 billion in 2022 and is expected to reach US$ 31.1 billion by 2030 growing with a CAGR of 8.3% during the forecast period 2024-2031. Key Drivers of the Anatomic Pathology Market in the USA: Rising cancer prevalence is driving demand for accurate diagnostic tools. Technological advancements are improving pathology automation and digital imaging. Aging population increases the need for disease diagnosis and monitoring. Growing personalized medicine boosts

Global Drug Screening Market Surges Amid Rising Substance Abuse and Workplace Sa …

The Global Drug Screening Market is expected to grow at a CAGR of 17.1% during the forecasting period (2024-2031). Key Drivers of the Drug Screening Market in the USA: Rising substance abuse cases are increasing the demand for early detection solutions. Strict government regulations mandate drug testing in workplaces and transportation. Advancements in drug screening technologies improve accuracy and reduce testing time. Growing use of drug tests in sports and healthcare drives market adoption. Increased corporate

Pterygium Drug Market Demonstrates Robust Growth Potential Through 2031 Forecast …

New Jersey, US State: "The global Pterygium Drug market in the Healthcare and Pharmaceuticals category is projected to reach USD 450 million by 2031, growing at a CAGR of 4.5% from 2025 to 2031. With rising industrial adoption and continuous innovation in Healthcare and Pharmaceuticals applications, the market is estimated to hit USD 310 million in 2024, highlighting strong growth potential throughout the forecast period." Pterygium Drug Market Size & Forecast

Pericarditis Market Set to Surge with Innovative Therapies and Rising Prevalence …

The Global Pericarditis Market is expected to reach at a Significant CAGR during the forecast period 2024-2031. Key Drivers of the Pericarditis Market in the USA: Rising prevalence of cardiovascular diseases increases the demand for pericarditis diagnosis and treatment. Advancements in imaging and diagnostic tools enhance early detection and accurate diagnosis. Increased awareness among healthcare professionals leads to more frequent identification of pericarditis cases. Growing elderly population raises the risk of heart-related conditions, including pericarditis. Ongoing

Central Fill Pharmacy Automation Market Generated Opportunities, Future Scope 20 …

The qualitative latest Research report (2025-2032) on the Central Fill Pharmacy Automation Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/5189 Focused on

Global Central Lab Market to Witness Massive Growth by 2032 | Bioscientia (Sonic …

The Global Central Lab Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2025 and 2032. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The Industry compass guiding business through the complexities of the market, presenting not only the current landscape but also the latest innovations shaping its future.

Cell Sorting Market Report: Growth Dynamics and Forecast Opportunities By 2025-2 …

The cell sorting industry is rapidly evolving, driven by precision medicine and high-throughput research demands. As researchers and biopharma firms pursue targeted therapies, advanced cell separation technologies gain prominence, shaping market dynamics and business growth. Market Size and Overview The Global Cell Sorting Market is estimated to be valued at USD 265.2 Mn in 2025 and is expected to reach USD 477.3 Mn by 2032, exhibiting a compound annual growth rate

Eylea Market Future Business Opportunities 2025-2032 | Bayer AG, Bausch + Lomb, …

The Global Eylea Market is estimated to be valued at USD 838.6 Mn in 2025 and is expected to reach USD 673.7 Mn by 2032, declining at a negative compound annual growth rate (CAGR) of -3.1% from 2025 to 2032. This Eylea market size projection aligns with rising prevalence of diabetic retinopathy and age-related macular degeneration. The ophthalmology therapeutics industry has been revolutionized by targeted anti-VEGF agents, with Eylea commanding a

Remicade Market Generated Opportunities, Future Scope 2025-2032 | Janssen Biotec …

The Global Remicade Market is estimated to be valued at USD 1,584.3 Mn in 2025 and is expected to reach USD 1,062.3 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of -2.78% from 2025 to 2032, this market analysis encompasses market scope and dynamics across indications and geographies and highlights emerging market opportunities and challenges. The Global Remicade Market size is estimated to be valued at USD 5.2 billion

Lenalidomide Drug Market Future Business Opportunities 2025-2032 | Bristol-Myers …

The lenalidomide drug market is estimated to be valued at USD 14.08 Bn in 2025 and is expected to reach USD 22.04 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032. This market size projection integrates diverse geographies, portfolio expansions, and evolving market opportunities across oncology portfolios. The Lenalidomide Drug Market report underscores robust business growth driven by multiple myeloma indications and emerging

Pharmaceutical intermediates Market Future Business Opportunities 2025-2032 | Lo …

The pharmaceutical intermediates market is estimated to be valued at USD 47.30 Bn in 2025 and is expected to reach USD 82.70 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2032. This projection underscores Global Pharmaceutical Intermediates Market revenue growth and highlights market forecast precision. Pharmaceutical intermediates serve as essential building blocks in drug synthesis, underpinning pipelines for both small-molecule and biologic APIs.

Bleeding Control Kit Market Forecast 2034: Growing Focus on First Response Readi …

The Bleeding Control Kit (BCK) market plays a crucial role in trauma care, offering essential tools for controlling bleeding in emergencies. These kits, also known as Stop the Bleed or Trauma Kits, are designed to provide individuals with basic hemorrhage control tools, such as tourniquets, medical gloves, and dressings. The purpose of this report is to provide a detailed analysis of the global Bleeding Control Kit Market, focusing on sector analysis,

Military and Humanitarian Trauma Care Market Forecast 2034: Tactical Medical Inn …

The global Military and Humanitarian Trauma Care Market, valued at USD 7.0 billion in 2023, is poised for significant growth over the next decade. With a projected compound annual growth rate (CAGR) of 6.7% from 2024 to 2034, the market is expected to exceed USD 14.2 billion by the end of 2034. This growth is largely driven by the increasing incidence of traumatic injuries due to factors such as road traffic

Pen Needles Market for Diabetes and Chronic Drug Delivery | Driven by Safety-Eng …

Pen Needles Market reached US$ 3.5 billion in 2023 and is expected to reach US$ 8.5 billion by 2031, growing with a CAGR of 11.8% during the forecast period 2024-2031. The Pen Needles Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of

Retinal Vein Occlusion Market Forecast 2034: Advancements in Ophthalmic Treatmen …

The global retinal vein occlusion market was valued at USD 2.8 billion in 2023 and is poised for significant growth in the coming years. With a projected compound annual growth rate (CAGR) of 6.7% from 2024 to 2034, the market is expected to exceed USD 5.5 billion by the end of 2034. This growth is driven by advancements in diagnostic and therapeutic options, increasing prevalence of risk factors such as hypertension

Organic Period Care Products Market Forecast 2034: Consumer Shift Toward Sustain …

The global organic period care products market is on a transformative journey, driven by the rising demand for sustainable, chemical-free, and eco-friendly menstrual solutions. Valued at USD 2.6 billion in 2023, this sector is projected to grow at a compound annual growth rate (CAGR) of 6.6%, reaching USD 5.2 billion by 2034. This report aims to provide an in-depth analysis of the market, exploring sector dynamics, competition, new developments, growth drivers,

Golf Apparel & Shoes Market Forecast 2034: Lifestyle Trends and Rising Participa …

The global golf apparel and shoes market is undergoing a significant transformation, driven by an expanding demographic of players, evolving consumer preferences, and rapid technological advancements. Valued at USD 10.0 billion in 2023, the industry is projected to grow at a compound annual growth rate (CAGR) of 4.9% over the forecast period, reaching an estimated market value of USD 16.7 billion by 2034. Access key findings and insights from our Report in

Go To Page     10958 10957 10956 10955 10954 10953 10952 10951 10950 10949 7918 7917 7916 7915 7914 7913 7912 7911 7910 7909